Brief report · 29 Dec 2025
Conference abstractPublished 16 May 2016
Point of care diagnosis of bacterial vaginosis by detection of biogenic amines using ion mobility spectrometry (IMS) in a routine ambulatory care gynecology clinic
SeraDiaLogistics Munich, Germany
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Purpose: A new CE-marked portable desktop ion mobility spectrometer (VGTest) was used for detection of malodorous biogenic amines indicative of bacterial vaginosis (BV). This study aimed to assess the performance of this testing method for the first time in a routine ambulatory care clinic and to determine the relative levels of biogenic amines in vaginal fluid of BV. Methods: Vaginal and cervical swabs (n=57) were surveyed for infections. Cases of BV (n=18) confirmed positive according to âÂ?Â?âÂ?Â?AmselâÂ?Â?âÂ?Â? criteria and normal controls (n=39) showing no infection under clinical examination and testing negative in wet mount microscopy were included in the IMS analysis. Results: The trimethylamine (TMA) content in vaginal fluid of the BV-positive cases, AUCTMA/AUCTotal [mean 0.215 (range 0.15âÂ?Â? 0.35)] was significantly higher than normal controls [mean 0.06 (range 0.048âÂ?Â?0.07)] p\0.0001. The putrescine (1,4-diaminobutane, PUT) and cadaverine (1,5-diaminopentane, CAD) of BV-positive cases were above controls at borderline significance. The AUCTMA/AUCTotal ratios correlated neither with AUCPUT/ AUCTotal nor AUCCAD/AUCTotal among BV-positive patients. In contrast, among normal controls all the biogenic amines were at a low level and the linear regression analysis revealed striking positive correlations of AUCTMA/AUCTotal with AUCPUT/AUCTotal (p\0.05) and AUCCAD/AUCTotal (p\0.001). The test shows 83% sensitivity and 92% specificity at a cut-off of AUCTMA/ AUCTotal=0.112 and AUC of receiver operator characteristic = 0.915 (0.81âÂ?Â?0.97, 95% CI). Conclusions: VGTest-IMS is accurate and feasible for point-of-care testing of BV in the ambulatory care setting. Further evaluations are in progress to assess the utility of VGTest-IMS for differential diagnosis of candidosis, non-BV infection and common inflammatory conditions.
Subjects
Biochemistry & BiotechnologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Metabolomics:Open Access.
Perspective · 29 Dec 2025
Metabolomics: Assessing Environmental Health and Risk
Brief report · 29 Dec 2025
Metabolite Quantification: Accuracy, Standards, Applications
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMetabolomics:Open Access
- SubjectBiochemistry & Biotechnology
- BylineArticles whose byline prints “Simon D Lytton”
